1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO
Gao, M, O'Boyle, D.R, Lemm, J.A, Fridell, R.A, Wang, C, Roberts, S, Liu, M, Nower, P, Wang, Y.-K, Johnson, B.M, Kramer, M, Moulin, F, Nophsker, M.J, Hewawasam, P, Kadow, J, Cockett, M, Meanwell, N.A, Belema, M, Sun, J.-H
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
787 BMS-766, A NOVEL HCV NS5A INHIBITOR WITH ENHANCED RESISTANCE COVERAGE
Gao, M, Fridell, R, Wang, C, Sun, J.-H, O'boyle, D, Valera, L, Nower, P, Monikowski, A, Kirk, M, Huang, H, Ngo, C, Fang, H, Knox, R, Wang, Y.-K, Nguyen, V, Wang, F, Snyder, L, Lavoie, R, Bender, J, Kadow, J, Cockett, M, Meanwell, N, Belema, M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine -Oxidation and Rearrangement
Li, W., Zhao, W., Liu, X., Huang, X., Lopez, O. D., Leet, J. E., Fancher, R. M., Nguyen, V., Goodrich, J., Easter, J., Hong, Y., Caceres-Cortes, J., Chang, S. Y., Ma, L., Belema, M., Hamann, L. G., Gao, M., Zhu, M., Shu, Y.-Z., Humphreys, W. G., Johnson, B. M.
Published in Drug metabolism and disposition (29.04.2016)
Published in Drug metabolism and disposition (29.04.2016)
Get full text
Journal Article
Synthesis of carbon-14 labeled (R)-3-fluoro-4-(2′-(5′′, 6′′, 7′′, 8′′-tetrahydro-5′′, 5′′, 8′′, 8′′-tetramethyl-2′′-naphthyl)-[2′-hydroxy-14C])[carbonyl-14C]acetamidobenzoic acid
Dischino, Douglas D., Lee, Che-Wah, Belema, Makonen, Zusi, Christopher
Published in Journal of labelled compounds & radiopharmaceuticals (01.02.2003)
Published in Journal of labelled compounds & radiopharmaceuticals (01.02.2003)
Get full text
Journal Article